Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 29.30

+2.1%

3:49 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (4961)	3/18/1999 9:43:00 PM
From: Cacaito	Read Replies (2) of 5736

Confirmation #2, Sprx is testing the Bilicheck during Phototherapy, six hospitals in Europe. This is from communication via Sprx e-mail. My opinion: I post before: there are not technical reasons why the Bilicheck could not work during phototherapy treatment. The reason for approval for pre-phototherapy was to get product out sooner (and they did). Later, they will apply for the during phototherapy measures. Very clever. Competition is here.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next